|
KRR1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.766600E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.976600E-04 |
| Normal-vs-Stage2 |
4.998100E-02 |
| Normal-vs-Stage3 |
2.450300E-02 |
| Normal-vs-Stage4 |
4.742200E-02 |
| Stage1-vs-Stage2 |
8.674000E-01 |
| Stage1-vs-Stage3 |
6.296800E-01 |
| Stage1-vs-Stage4 |
9.500800E-01 |
| Stage2-vs-Stage3 |
8.252400E-01 |
| Stage2-vs-Stage4 |
9.572000E-01 |
| Stage3-vs-Stage4 |
8.035800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.646300E-04 |
| Normal-vs-AfricanAmerican |
2.096400E-02 |
| Normal-vs-Asian |
2.474400E-01 |
| Caucasian-vs-AfricanAmerican |
4.945600E-01 |
| Caucasian-vs-Asian |
7.086000E-01 |
| AfricanAmerican-vs-Asian |
8.909800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.16210000000472E-05 |
| Normal-vs-Female |
4.486000E-01 |
| Male-vs-Female |
9.809000E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.844000E-03 |
| Normal-vs-Extreme_Weight |
1.89339999999705E-05 |
| Normal-vs-Obese |
2.513500E-02 |
| Normal-vs-Extreme_Obese |
1.724270E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.777000E-01 |
| Normal_Weight-vs-Obese |
5.243600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.681000E-01 |
| Extreme_Weight-vs-Obese |
4.863700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.317000E-01 |
| Obese-vs-Extreme_Obese |
1.862040E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.946200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.440300E-02 |
| Normal-vs-Age(61-80Yrs) |
3.96180000000745E-05 |
| Normal-vs-Age(81-100Yrs) |
2.031100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.654630E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.667880E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.398500E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.171900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.204400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.763200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.370800E-04 |
| Normal-VS-Type2 PRCC |
3.97890000003454E-06 |
| Normal-VS-KIRP CIMP |
7.224800E-01 |
| Normal-VS-Unclassified PRCC |
2.581400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.454400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.607900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.168000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.597500E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
4.173900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.444600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.65426999999552E-05 |
| Normal-vs-N1 |
8.049600E-01 |
| Normal-vs-N2 |
3.342300E-02 |
| N0-vs-N1 |
1.522680E-03 |
| N0-vs-N2 |
9.390400E-01 |
| N1-vs-N2 |
2.099200E-01 |
|
|
